Medicure (MCUJF) Restructuring Costs (2009 - 2024)

Medicure (MCUJF) posted quarterly Restructuring Costs of -$1.4 million for Q3 2024, down 303.7% quarter-over-quarter from $669344.9 in Q2 2017.

Medicure (MCUJF) Restructuring Costs (2009 - 2024) Analysis & Trends

Medicure's Restructuring Costs history runs 8 years deep, the most recent figure standing at -$1.4 million for Q3 2024.

In Q3 2024, Restructuring Costs changed N/A year-over-year to -$1.4 million; the TTM figure through Sep 2024 stood at -$1.4 million (changed N/A YoY), while the FY2015 annual figure was $743360.7, up 126.34% from the prior year.
Restructuring Costs for Q3 2024 stood at -$1.4 million, down from $669344.9 in the prior quarter.
The five-year high for Restructuring Costs was -$1.4 million in Q3 2024, with the low at -$1.4 million in Q3 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	43.83 Bn	42.86 Bn	-
2	Teva Pharmaceutical Industries	42.87 Bn	39.22 Bn	2.15 Bn
3	Zoetis	31.41 Bn	29.73 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.55 Bn	22.75 Bn	5.10 Bn
5	United Therapeutics	22.08 Bn	19.42 Bn	683.80 Mn
6	Viatris	18.73 Bn	17.84 Bn	1.46 Bn
7	Neurocrine Biosciences	15.44 Bn	15.05 Bn	935.80 Mn
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.11 Bn	9.94 Bn	-
10	Medicure	96.01 Mn	94.89 Mn	2.57 Mn

Download Data